Comorbidities of migraine

Shuu-Jiun Wang, Ping-Kun Chen, Jong-Ling Fuh, Shuu-Jiun Wang, Ping-Kun Chen, Jong-Ling Fuh

Abstract

Migraine is a common neurological disorder and can be severely disabling during attacks. The highest prevalence occurs between the ages of 25 and 55 years, potentially the most productive period of life. Migraine leads to a burden not only for the individual, but also for the family and society in general. Prior studies have found that migraine occurs together with other illnesses at a greater coincidental rate than is seen in the general population. These occurrences are called "comorbidities," which means that these disorders are interrelated with migraine. To delineate the comorbidities of migraine is important, because it can help improve treatment strategies and the understanding of the possible pathophysiology of migraine. The comorbid illnesses in patients with migraine include stroke, sub-clinical vascular brain lesions, coronary heart disease, hypertension, patent foramen ovale, psychiatric diseases (depression, anxiety, bipolar disorder, panic disorder, and suicide), restless legs syndrome, epilepsy and asthma. In this paper, we review the existing epidemiological and hospital-based studies, and illustrate the connections between these illnesses and migraine.

Keywords: anxiety; cerebrovascular disorder; comorbidity; depression; migraine.

References

    1. Aamodt A. H., Stovner L. J., Langhammer A., Hagen K., Zwart J. A. (2007). Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT Study. Headache 47, 204–21210.1111/j.1526-4610.2006.00597.x
    1. Alehan F., Ozçay F., Erol I., Canan O., Cemil T. (2008). Increased risk for coeliac disease in paediatric patients with migraine. Cephalalgia 28, 945–94910.1111/j.1468-2982.2008.01630.x
    1. Andlin-Sobocki P., Jönsson B., Wittchen H. U., Olesen J. (2005). Cost of disorders of the brain in Europe. Eur. J. Neurol. 12, 1–2710.1111/j.1468-1331.2005.01202.x
    1. Anzola G. P., Magoni M. D., Guindani M., Rozzini L., Dalla Volta G. D. (1999). Potential source of cerebral embolism in migraine with aura. A transcranial Doppler study. Neurology 52, 1622–1625
    1. Azpiroz F., Dapoigny M., Pace F., Müller-Lissner S., Coremans G., Whorwell P., Stockbrugger R. W., Smout A. (2000). Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 62, 66–7210.1159/000007780
    1. Barden N. (2004). Implication of the hypothalamic–pituitary–adrenal axis in the physiopathology of depression. J. Psychiatry Neurosci. 29, 185–193
    1. Baykan B., Madia F., Bebek N., Gianotti S., Güney A. I., Cine N., Bianchi A., Gökyiğit A., Zara F. (2004). Autosomal recessive idiopathic epilepsy in an inbred family from Turkey: identification of a putative locus on chromosome 9q32–33. Epilepsia 45, 479–48710.1111/j.0013-9580.2004.30903.x
    1. Becker C., Brobert G. P., Almqvist P. M., Johansson S., Jick S. S., Meier C. R. (2008). The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions. Headache 48, 606–61010.1111/j.1526-4610.2007.01030.x
    1. Bigal M. E., Kurth T., Santanello N., Buse D., Golden W., Robbins M., Lipton R. B. (2010). Migraine and cardiovascular disease: a population-based study. Neurology 74, 628–63510.1212/WNL.0b013e3181d0cc8b
    1. Bigal M. E., Liberman J. N., Lipton R. B. (2006). Obesity and migraine: a population study. Neurology 66, 545–55010.1212/01.wnl.0000197218.05284.82
    1. Bigal M. E., Tsang A., Loder E., Serrano D., Reed M. L., Lipton R. B. (2007a). Body mass index and episodic headaches: a population-based study. Arch. Intern. Med. 167, 1964–197010.1001/archinte.167.18.1964
    1. Bigal M. E., Lipton R. B., Holland P. R., Goadsby P. J. (2007b). Obesity, migraine and chronic migraine: possible mechanisms of interaction. Neurology 68, 1851–186110.1212/01.wnl.0000262045.11646.b1
    1. Bonavita V., De Simone R. (2008). Towards a definition of comorbidity in the light of clinical complexity. Neurol. Sci. 29, S99–S10210.1007/s10072-008-0898-1
    1. Bousser M. G., Conard J., Kittner S., de Lignières B., MacGregor E. A., Massiou H., Silberstein S. D., Tzourio C. (2000). Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 20, 155–156
    1. Breslau N. (1992). Migraine, suicidal ideation, and suicide attempts. Neurology 42, 392–395
    1. Breslau N., Davis G. C., Andreski P. (1991). Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 37, 11–2310.1016/0165-1781(91)90102-U
    1. Breslau N., Davis G. C., Schultz L. R., Peterson E. L. (1994). Migraine and major depression: A longitudinal study. Headache 34, 387–39310.1111/j.1526-4610.1994.hed3407387.x
    1. Breslau N., Lipton R. B., Stewart W. F., Schultz L. R., Welch K. M. (2003). Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60, 1308–1312
    1. Breslau N., Schultz L. R., Stewart W. F., Lipton R. B., Lucia V. C., Welch K. M. A. (2000). Headache and major depression: Is the association specific to migraine? Neurology 54, 308–313
    1. Breslau N., Schultz L. R., Stewart W. F., Lipton R. B., Welch K. M. A. (2001). Headache types and panic disorder. Neurology 56, 350–354
    1. Buzzi M. G., Moskowitz M. A. (2005). The pathophysiology of migraine: year 2005. J. Headache Pain 6, 105–11110.1007/s10194-005-0165-2
    1. Carod-Artal F. J., da Silveira Ribeiro L., Braga H., Kummer W., Mesquita H. M., Vargas A. P. (2006). Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 26, 934–93910.1111/j.1468-2982.2006.01156.x
    1. Chen P. K., Fuh J. L., Chen S. P., Wang S. J. (2010). Association between restless legs syndrome and migraine. J. Neurol. Neurosurg. Psychiatr. 81, 524–52810.1136/jnnp.2009.191684
    1. Cirillo M., Stellato D., Lombardi C., De Santo N. G., Covelli V. (1999). Headache and cardiovascular risk factors: positive association with hypertension. Headache 39, 409–41610.1046/j.1526-4610.1999.3906409.x
    1. Cole J. A., Rothman K. J., Cabral H. J., Zhang Y., Farraye F. A. (2006). Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 6, 26.10.1186/1471-230X-6-26
    1. Dahmen N., Kasten M., Wieczorek S., Gencik M., Epplen J. T., Ullrich B. (2003). Increased frequency of migraine in narcoleptic patients: a confirmatory study. Cephalalgia 23, 14–1910.1046/j.1468-2982.2003.00343.x
    1. Dahmen N., Querings K., Grün B., Bierbrauer J. (1999). Increased frequency of migraine in narcoleptic patients. Neurology 52, 1291–1293
    1. Del Sette M., Angeli S., Leandri M., Ferriero G., Bruzzone G. L., Finocchi C., Gandolfo C. (1998). Migraine with aura and right-to-left shunt on transcranial Doppler: a case–control study. Cerebrovasc. Dis. 8, 327–33010.1159/000015875
    1. Deprez L., Peeters K., Van Paesschen W., Claeys K. G., Claes L. R., Suls A., Audenaert D., Van Dyck T., Goossens D., Del-Favero J., De Jonghe P. (2007). Familial occipitotemporal lobe epilepsy and migraine with visual aura: linkage to chromosome 9q. Neurology 68, 1995–200210.1212/01.wnl.0000262764.78511.17
    1. de Tommaso M., Sardaro M., Serpino C., Costantini F., Vecchio E., Prudenzano M. P., Lamberti P., Livrea P. (2009). Fibromyalgia comorbidity in primary headaches. Cephalalgia 29, 453–46410.1111/j.1468-2982.2008.01754.x
    1. DMKG Study Group. (2003). Migraine and idiopathic narcolepsy–a case-control study. Cephalalgia 23, 786–78910.1046/j.1468-2982.2003.00594.x
    1. d'Onofrio F., Bussone G., Cologno D., Petretta V., Buzzi M. G., Tedeschi G., Bonavita V., Cicarelli G. (2008). Restless legs syndrome and primary headaches: a clinical study. Neurol. Sci. 29(Suppl. 1), S169–S17210.1007/s10072-008-0916-3
    1. Dowson A., Mullen M. J., Peatfield R., Muir K., Khan A. A., Wells C., Lipscombe S. L., Rees T., De Giovanni J. V., Morrison W. L., Hildick-Smith D., Elrington G., Hillis W. S., Malik I. S., Rickards A. (2008). Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117, 1397–140410.1161/CIRCULATIONAHA.107.727271
    1. Elkind M. S. (2008). Endothelial repair capacity and migraine: the fix is in. Neurology 70, 1506–150710.1212/01.wnl.0000310647.04081.3c
    1. Ferrari M. D., Saxena P. R. (1993). On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 13, 151–16510.1046/j.1468-2982.1993.1303151.x
    1. Ferrarini G., Malferrari G., Zucco R., Gaddi O., Norina M., Pini L. A. (2005). High prevalence of patent foramen ovale in migraine with aura. J. Headache Pain 6, 71–7610.1007/s10194-005-0154-5
    1. Ford E. S., Li C., Pearson W. S., Zhao G., Strine T. W., Mokdad A. H. (2008). Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 28, 1270–127610.1111/j.1468-2982.2008.01671.x
    1. Franceschi M., Colombo B., Rossi P., Canal N. (1997). Headache in a population-based elderly cohort. An ancillary study to the Italian Longitudinal Study of Aging (ILSA). Headache 37, 79–8210.1046/j.1526-4610.1997.3702079.x
    1. Gabrielli M., Cremonini F., Fiore G., Addolorato G., Padalino C., Candelli M., De Leo M. E., Santarelli L., Giacovazzo M., Gasbarrini A., Pola P., Gasbarrini A. (2003). Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am. J. Gastroenterol. 98, 625–62910.1111/j.1572-0241.2003.07300.x
    1. Glanz B. I., Venkatesan A., Schur P. H., Lew R. A., Khoshbin S. (2001). Prevalence of migraine in patients with systemic lupus erythematosus. Headache 41, 285–28910.1046/j.1526-4610.2001.111006285.x
    1. Hagen K., Einarsen C., Zwart J. A., Svebak S., Bovim G. (2002). The co-occurrence of headache and musculoskeletal symptoms amongst 51,050 adults in Norway. Eur. J. Neurol. 9, 527–53310.1046/j.1468-1331.2002.00451.x
    1. Hamel E. (2007). Serotonin and migraine: biology and clinical implications. Cephalalgia 27, 1293–130010.1111/j.1468-2982.2007.01476.x
    1. Ifergane G., Buskila D., Simiseshvely N., Zeev K., Cohen H. (2006). Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 26, 451–45610.1111/j.1468-2982.2005.01060.x
    1. Jesurum J. T., Fuller C. J., Kim C. J., Krabill K. A., Spencer M. P., Olsen J. V., Likosky W. H., Reisman M. (2008). Frequency of migraine headache relief following patent foramen ovale “closure” despite residual right-to-left shunt. Am. J. Cardiol. 102, 916–92010.1016/j.amjcard.2008.05.035
    1. Juang K. D., Wang S. J., Fuh J. L., Lu S. R., Su T. O. (2000). Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 40, 818–82310.1046/j.1526-4610.2000.00148.x
    1. Karaali-Savrun F., Göksan B., Yeni S. N., Ertan S., Uzun N. (2002). Seizure-related headache in patients with epilepsy. Seizure 11, 67–6910.1053/seiz.2001.0583
    1. Kessler R. C., McGonagle K. A., Zhao S., Nelson C. B., Hughes M., Eshleman S., Wittchen H. U., Kendler K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51, 8–19
    1. Kruit M. C., Launer L. J., Ferrari M. D., van Buchem M. A. (2005). Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 128, 2068–207710.1093/brain/awh542
    1. Kruit M. C., van Buchem M. A., Hofman P. A., Bakkers J. T., Terwindt G. M., Ferrari M. D., Launer L. J. (2004). Migraine as a risk factor for subclinical brain lesions. JAMA 291, 427–434
    1. Kurth T., Gaziano J. M., Cook N., Bubes V., Logroscino G., Diener H. C., Buring J. E. (2007). Migraine and risk of cardiovascular disease in men. Arch. Intern. Med. 167, 795–80110.1001/archinte.167.8.795
    1. Kurth T., Gaziano J. M., Cook N. R., Logroscino G., Diener H. C., Buring J. E. (2006). Migraine and risk of cardiovascular disease in women. JAMA 296, 283–291
    1. Kurth T., Schürks M., Logroscino G., Gaziano J. M., Buring J. E. (2008). Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 337, a636.
    1. Kurth T., Slomke M. A., Kase C. S., Cook N. R., Lee I. M., Gaziano J. M., Diener H. C., Buring J. E. (2005). Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64, 1020–1026
    1. Lea R. A., Ovcaric M., Sundholm J., Solyom L., Macmillan J., Griffiths L. R. (2005). Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res. Mol. Brain Res. 136, 112–117710.1016/j.molbrainres.2005.01.006
    1. Lee S. T., Chu K., Jung K. H., Kim D. H., Kim E. H., Choe V. N., Kim J. H., Im W. S., Kang L., Park J. E., Park H. J., Park H. K., Song E. C., Lee S. K., Kim M., Roh J. K. (2008). Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 70, 1510–151710.1212/01.wnl.0000294329.93565.94
    1. Lipton R. B., Ottman R., Ehrenberg B. L., Hauser W. A. (1994). Comorbidity of migraine: the connection between migraine and epilepsy. Neurology 44(10 Suppl. 7), S28–S32
    1. Lipton R. B., Silberstein S. D. (1994). Why study the comorbidity of migraine? Neurology 44(10 Suppl. 7), S4–S5
    1. Lipton R. B., Stewart W. F., Diamond S., Diamond M. L., Reed M. (2001). Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41, 646–65710.1046/j.1526-4610.2001.041007646.x
    1. Low N. C., DuFort G. G., Cervantes P. (2003). Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache 43, 940–94910.1046/j.1526-4610.2003.03184.x
    1. Lu S. R., Fuh J. L., Chen W. T., Juang K. D., Wang S. J. (2001). Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21, 980–98610.1046/j.1468-2982.2001.00294.x
    1. Lu S. R., Fuh J. L., Juang K. D., Wang S. J. (2000). Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. Headache 40, 724–72910.1046/j.1526-4610.2000.00126.x
    1. Mahmood T., Romans S., Silverstone T. (1999). Prevalence of migraine in bipolar disorder. J. Affect. Disord. 52, 239–24110.1016/S0165-0327(98)00082-2
    1. Marazziti D., Toni C., Pedri S., Bonuccelli U., Pavese N., Lucetti C., Nuti A., Muratorio A., Cassano G. B. (1999). Prevalence of headache syndromes in panic disorder. Int. Clin. Psychopharmacol. 14, 247–25110.1097/00004850-199907000-00007
    1. Marks D. A., Ehrenberg B. L. (1993). Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 43, 2476–2483
    1. Martin V. T., Behbehani M. (2006). Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis–part I. Headache 46, 3–2310.1111/j.1526-4610.2006.00309.x
    1. McWilliams L. A., Goodwin R. D., Cox B. J. (2004). Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 111, 77–83
    1. Merikangas K. R., Angst J., Isler H. (1990). Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch. Gen. Psychiatry 47, 849–853
    1. Mizutani W. T., Hutchinson M., Ouismorio F. P. (1985). Association of migraine headache and Raynaud's phenomenom in systemic lupus erythematosus. Arthritis Rheum. 28, S63
    1. Mulak A., Paradowski L. (2005). Migraine and irritable bowel syndrome. Neurol. Neurochir. Pol. 39, S55–S60
    1. Nuyen J., Schellevis F. G., Satariano W. A., Spreeuwenberg P. M., Birkner M. D., van den Bos G. A., Groenewegen P. P. (2006). Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J. Clin. Epidemiol. 59, 1274–128410.1016/j.jclinepi.2006.01.005
    1. Peres M. F., Sanchez del Rio M., Seabra M. L., Tufik S., Abucham J., Cipolla-Neto J., Silberstein S. D., Zukerman E. (2001). Hypothalamic involvement in chronic migraine. J. Neurol. Neurosurg. Psychiatr. 71, 747–75110.1136/jnnp.71.6.747
    1. Peres M. F., Young W. B., Kaup A. O., Zukerman E., Silberstein S. D. (2001). Fibromyalgia is common in patients with transformed migraine. Neurology 57, 1326–1328
    1. Peres M. F., Zukerman E., Young W. B., Silberstein S. D. (2002). Fatigue in chronic migraine patients. Cephalalgia 22, 720–72410.1046/j.1468-2982.2002.00426.x
    1. Peterlin B. L., Rosso A. L., Rapoport A. M., Scher A. I. (2010). Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 50, 52–6210.1111/j.1526-4610.2009.01459.x
    1. Post M., Thijs V., Herroelen L., Budts W. (2004). Closure of patent ovale is associated with decrease in prevalence of migraine. Neurology 62, 1439–1440
    1. Rasmussen B. K., Olesen J. (1992). Symptomatic and nonsymptomatic headaches in a general population. Neurology 42, 1225–1231
    1. Rhode A. M., Hösing V. G., Happe S., Biehl K., Young P., Evers S. (2007). Comorbidity of migraine and restless legs syndrome–a case-control study. Cephalalgia 27, 1255–126010.1111/j.1468-2982.2007.01453.x
    1. Rose K. M., Carson A. P., Sanford C. P., Stang P. E., Brown C. A., Folsom A. R., Szklo M. (2004). Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology 63, 2233–2239
    1. Rundek T., Elkind M. S., Di Tullio M. R., Carrera E., Jin Z., Sacco R. L., Homma S. (2008). Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 118, 1419–142410.1161/CIRCULATIONAHA.108.771303
    1. Saka E., Saygi S. (2000). Familial adult onset myoclonic epilepsy associated with migraine. Seizure 9, 344–34610.1053/seiz.2000.0402
    1. Scher A. I., Bigal M. E., Lipton R. B. (2005a). Comorbidity of migraine. Curr. Opin. Neurol. 18, 305–31010.1097/01.wco.0000169750.52406.a2
    1. Scher A. I., Terwindt G. M., Picavet H. S., Verschuren W. M., Ferrari M. D., Launer L. J. (2005b). Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64, 614–620
    1. Scher A. I., Gudmundsson L. S., Sigurdsson S., Ghambaryan A., Aspelund T., Eiriksdottir G., van Buchem M. A., Gudnason V., Launer L. J. (2009). Migraine headache in middle age and late-life brain infarcts. JAMA 301, 2563–2570
    1. Scher A. I., Terwindt G. M., Verschuren W. M., Kruit M. C., Blom H. J., Kowa H., Frants R. R., van den Maagdenberg A. M., van Buchem M., Ferrari M. D., Launer L. J. (2006). Migraine and MTHFR C677T genotype in a populationbased sample. Ann. Neurol. 59, 372–37510.1002/ana.20755
    1. Schürks M., Zee R. Y., Buring J. E., Kurth T. (2008). Interrelationships among the MTHFR 677C > T polymorphism, migraine, and cardiovascular disease. Neurology 71, 505–51310.1212/01.wnl.0000316198.34558.e5
    1. Schürks M., Zee R. Y., Buring J. E., Kurth T. (2009). ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology 72, 650–65610.1212/01.wnl.0000342517.97178.f6
    1. Schwedt T. J., Demaerschalk B. M., Dodick D. W. (2008). Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 28, 531–54010.1111/j.1468-2982.2008.01554.x
    1. Schwedt T. J., Dodick D. W. (2006). Patent foramen ovale and migraine: bringing closure to the subject. Headache 46, 663–67110.1111/j.1526-4610.2006.00433.x
    1. Schwerzmann M., Nedeltchev K., Lagger F., Mattle H. P., Windecker S., Meier B., Seiler C. (2005). Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65, 1415–141810.1212/01.wnl.0000179800.73706.20
    1. Schwerzmann M., Wiher S., Nedeltchev K., Mattle H. P., Wahl A., Seiler C. (2004). Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62, 1399–1401
    1. Smoller J. W., Pollack M. H., Wassertheil-Smoller S., Barton B., Hendrix S. L., Jackson R. D., Dicken T., Oberman A., Sheps D. S. (2003). Women's Health Initiative Investigators. Prevalence and correlates of panic attacks in postmenopausal women: Results from an ancillary study to the Women's Health Initiative. Arch. Intern. Med. 163, 2041–205010.1001/archinte.163.17.2041
    1. Stang P. E., Carson A. P., Rose K. M., Mo J., Ephross S. A., Shahar E., Szklo M. (2005). Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 64, 1573–157710.1212/01.WNL.0000158326.31368.04
    1. Stewart W. F., Breslau N., Keck P. E., Jr. (1994). Comorbidity of migraine and panic disorder. Neurology 44, S23–S27
    1. Stewart W. F., Linet M. S., Celentano D. D. (1989). Migraine headaches and panic attacks. Psychosom. Med. 51, 559–569
    1. Stewart W. F., Lipton R. B., Celentano D. D., Reed M. L. (1992). Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA 267, 64–69
    1. Terwindt G. M., Haan . J., Ophoff R. A., Groenen S. M., Storimans C. W., Lanser J. B., Roos R. A., Bleeker-Wagemakers E. M., Frants R. R., Ferrari M. D. (1998). Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 121, 303–31610.1093/brain/121.2.303
    1. Tietjen E. G. (2007). Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia 27, 981–98710.1111/j.1468-2982.2007.01407.x
    1. Tietjen G. E., Brandes J. L., Digre K. B., Baggaley S., Martin V., Recober A., Geweke L. O., Hafeez F., Aurora S. K., Herial N. A., Utley C., Khuder S. A. (2007). High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology 68, 134–14010.1212/01.wnl.0000251195.55563.02
    1. Tietjen G. E., Brandes J. L., Peterlin B. L., Eloff A., Dafer R. M., Stein M. R., Drexler E., Martin V. T., Hutchinson S., Aurora S. K., Recober A., Herial N. A., Utley C., White L., Khuder S. A. (2010). Childhood maltreatment and migraine (part III). Association with comorbid pain conditions. Headache 50, 42–5110.1111/j.1526-4610.2009.01558.x
    1. Tikka-Kleemola P., Artto V., Vepsäläinen S., Sobel E. M., Räty S., Kaunisto M. A., Anttila V., Hämäläinen E., Sumelahti M. L., Ilmavirta M., Färkkilä M., Kallela M., Palotie A., Wessman M. (2010). A visual migraine aura locus maps to 9q21–q22. Neurology 74, 1171–117710.1212/WNL.0b013e3181d8ffcb
    1. Troglio F., Echart C., Gobbi A., Pawson T., Pelicci P. G., De Simoni M. G., Pelicci G. (2004). The Rai (Shc C) adaptor protein regulates the neuronal stress response and protects against cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 101, 15476–1548110.1073/pnas.0403283101
    1. Tzourio C., Gagnière B., El Amrani M., Alpérovitch A., Bousser M. G. (2003). Relationship between migraine, blood pressure and carotid thickness. A population-based study in the elderly. Cephalalgia 23, 914–92010.1046/j.1468-2982.2003.00613.x
    1. Vandvik P. O., Wilhelmsen I., Ihlebaek C., Farup P. G. (2004). Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment. Pharmacol. Ther. 20, 1195–120310.1111/j.1365-2036.2004.02250.x
    1. Von Korff M., Crane P., Lane M., Miglioretti D. L., Simon G., Saunders K., Stang P., Brandenburg N., Kessler R. (2005). Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain 113, 331–339
    1. Wang S. J., Fuh J. L., Juang K. D., Lu S. R. (2009). Migraine and suicidal ideation in adolescents aged 13 to 15 years old. Neurology 72, 1146–115210.1212/01.wnl.0000345362.91734.b3
    1. Wang S. J., Fuh J. L., Lu S. R., Juang K. D. (2001). Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 89, 285–292
    1. Wang S. J., Fuh J. L., Young Y. H., Lu S. R., Shia B. C. (2000). Prevalence of migraine in Taipei, Taiwan: a population-based survey. Cephalalgia 20, 566–57210.1046/j.1468-2982.2000.00085.x
    1. Wang S. J., Juang K. D., Fuh J. L., Lu S. R. (2007). Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 68, 1468–147310.1212/01.wnl.0000260607.90634.d6
    1. Weder-Cisneros N. D., Téllez-Zenteno J. F., Cardiel M. H., Guibert-Toledano M., Cabiedes J., Velásquez-Paz A. L., García-Ramos G., Cantú C. (2004). Prevalence and factors associated with headache in patients with systemic lupus erythematosus. Cephalalgia 24, 1031–104410.1111/j.1468-2982.2004.00822.x
    1. Wiehe M., Fuchs S. C., Moreira L. B., Moraes R. S., Fuchs F. D. (2002). Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J. Hypertens. 20, 1303–130610.1097/00004872-200207000-00016
    1. Winter A. C., Berger K., Buring J. E., Kurth T. (2009). Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia 29, 269–27810.1111/j.1468-2982.2008.01716.x
    1. Younes R. P., De Long G. R., Neiman G., Rosner B. (1986). Manic-depressive illness in children: Treatment with lithium carbonate. J. Child Neurol. 1, 364–36810.1177/088307388600100409
    1. Young W. B., Piovesan E. J., Biglan K. M. (2003). Restless legs syndrome and drug-induced akathisia in headache patients. CNS Spectr. 8, 450–456
    1. Zelnik N., Pacht A., Obeid R., Lerner A. (2004). Range of neurologic disorders in patients with celiac disease. Pediatrics 113, 1672–167610.1542/peds.113.6.1672

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe